Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bistro I: BIBR 1048 in VTE Prevention after Hip Replacement
NCT02170701Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2000
- Primary completion
- Jun 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Started Oct 2000; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02170701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170701.